BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580 AND Prognosis
7 results:

  • 1. tnfaip3 mutation is an independent poor overall survival factor for patients with T-cell acute lymphoblastic leukemia.
    Chen C; Zhou L; Zhu L; Luo G; Wang L; Zeng C; Zhou H; Li Y
    Cancer Med; 2023 Feb; 12(4):3952-3961. PubMed ID: 36056685
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA.
    Zhang S; Zhang T; Liu H; Zhao J; Zhou H; Su X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; He J; Wang X; Zhang H
    Br J Haematol; 2022 Feb; 196(3):617-628. PubMed ID: 34664256
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A reduced panel of eight genes (ATM, SF3B1, NOTCH1, BIRC3, XPO1, MYD88, tnfaip3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemia.
    Chauzeix J; Pastoret C; Donaty L; Gachard N; Fest T; Feuillard J; Rizzo D
    Int J Lab Hematol; 2021 Aug; 43(4):683-692. PubMed ID: 33325634
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B.
    Kashyap MK; Kumar D; Villa R; La Clair JJ; Benner C; Sasik R; Jones H; Ghia EM; Rassenti LZ; Kipps TJ; Burkart MD; Castro JE
    Haematologica; 2015 Jul; 100(7):945-54. PubMed ID: 25862704
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tumor suppressor tnfaip3 (a20) is frequently deleted in Sézary syndrome.
    Braun FC; Grabarczyk P; Möbs M; Braun FK; Eberle J; Beyer M; Sterry W; Busse F; Schröder J; Delin M; Przybylski GK; Schmidt CA
    Leukemia; 2011 Sep; 25(9):1494-501. PubMed ID: 21625233
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
    Scandurra M; Rossi D; Deambrogi C; Rancoita PM; Chigrinova E; Mian M; Cerri M; Rasi S; Sozzi E; Forconi F; Ponzoni M; Moreno SM; Piris MA; Inghirami G; Zucca E; Gattei V; Rinaldi A; Kwee I; Gaidano G; Bertoni F
    Hematol Oncol; 2010 Jun; 28(2):62-7. PubMed ID: 20014148
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Constitutive NF-kappab/Rel activation in philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).
    Munzert G; Kirchner D; Ottmann O; Bergmann L; Schmid RM
    Leuk Lymphoma; 2004 Jun; 45(6):1181-4. PubMed ID: 15359998
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.